Risk for nevus transformation and melanoma proliferation and invasion during natalizumab treatment: four years of dermoscopic follow-up with immunohistological studies and proliferation and invasion assays

• Published in: JAMA dermatology (Chicago, Ill.) Vol. 150; no. 8; p. 901
• Main Authors: Pharaon, Momen, Tichet, Mélanie, Lebrun-Frénay, Christine, Tartare-Deckert, Sophie, Passeron, Thierry
• Format: Journal Article
• Language: English
• Published: United States 01.08.2014
• Subjects: Antibodies, Monoclonal, Humanized - pharmacology; Cell Line, Tumor; Cell Movement - drug effects; Cell Proliferation - drug effects; Cell Transformation, Neoplastic; Dermoscopy; Follow-Up Studies; Humans; Immunohistochemistry; Immunologic Factors - pharmacology; Integrin beta3 - analysis; Melanoma - chemistry; Melanoma - pathology; Multiple Sclerosis - drug therapy; Natalizumab; Nevus - chemistry; Nevus - pathology; Osteonectin - analysis; Skin Neoplasms - chemistry; Skin Neoplasms - pathology